• Naloxone Hydrochloride in Neural Stem Cell and Immunology Re

  2026-05-08

  Explore the advanced applications of Naloxone hydrochloride as an opioid receptor antagonist in neural stem cell proliferation and immune modulation research. This article delivers new mechanistic insights and protocol guidance, distinct from prior coverage, and highlights APExBIO’s high-purity reagent.

• Sulfo-Cy3 Azide: Precision Bioconjugation for Click Chemistr

  2026-05-07

  Sulfo-Cy3 azide empowers high-fidelity, water-based fluorescent labeling of biomolecules, outperforming conventional dyes in photostability and quenching resistance. Its robust compatibility with Click Chemistry and neurogenetic workflows streamlines protein and oligonucleotide labeling even in complex tissue samples.

• Ricin-Induced Bystander Necroptosis in Lung Epithelium: Mech

  2026-05-07

  Kempen et al. (2023) uncover a bystander mechanism of necroptotic lung epithelial cell death triggered by ricin and inflammatory mediators, providing new evidence for the role of macrophage-derived factors in propagating tissue injury. Their study emphasizes the complexity of cell death signaling in toxin-mediated lung damage and suggests new experimental approaches to dissect apoptosis versus necroptosis.

• GluN2A/B-Dependent Connexin Modulation in TMJ Inflammatory P

  2026-05-06

  This study reveals how NMDAR subunits GluN2A and GluN2B distinctly regulate gap junction proteins and pannexins in the trigeminal ganglion during temporomandibular joint (TMJ) inflammation. These mechanistic insights illuminate novel therapeutic targets in orofacial inflammatory allodynia and clarify the role of MAPK/ERK signaling in pain sensitization.

• Aconitase Activity Colorimetric Assay Kit: Reliable TCA Enzy

  2026-05-06

  This article explores real-world challenges in metabolic and oxidative stress research, demonstrating how the Aconitase Activity Colorimetric Assay Kit (SKU K2226) streamlines TCA cycle enzyme assays with rapid, reproducible, and sensitive detection. Drawing on validated protocols and comparative data, we show why this kit is a trusted solution for mitochondrial aconitase activity and oxidative damage measurement.

• BMS-777607: Strategic MET Pathway Inhibition for Translation

  2026-05-05

  This article offers a thought-leadership perspective on leveraging the selective c-Met inhibitor BMS-777607 in translational research. Integrating mechanistic insights from oncology and recent stem cell studies, it provides evidence-backed guidance for protocol design, discusses cross-domain opportunities, and positions BMS-777607 as a cornerstone for reproducible, advanced biomedical workflows.

• Auranofin: Redox Modulation, Mechanotransduction, and Cytosk

  2026-05-05

  Discover how Auranofin, a potent thioredoxin reductase inhibitor, uniquely bridges redox modulation and cytoskeleton-dependent autophagy, opening new avenues in cancer research and oxidative stress studies. This article provides a deeper mechanistic analysis and practical assay insights.

• HOBt (1-Hydroxybenzotriazole) in Modern Peptide Synthesis

  2026-05-04

  HOBt (1-Hydroxybenzotriazole) delivers unmatched control over amide bond formation, minimizing epimerization and unlocking access to complex peptide and antibiotic derivative synthesis. This article translates advanced reference workflows into actionable lab protocols and troubleshooting tips, guiding researchers from bench to breakthrough with APExBIO's high-purity HOBt.

• GPNMB-Based Model Predicts Immunotherapy Response in ESCC

  2026-05-04

  This study introduces a multimodal model using circulating GPNMB and CAF-Epi niche features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). The work clarifies how tumor-derived sGPNMB drives CD8+ T cell exhaustion, providing a validated, clinically scalable approach for precision immunotherapy.

• Combinational Targeting of eIF4F, AKT1, and EZH2 in BRAFV600

  2026-05-03

  This study uncovers that combined inhibition of the eIF4F complex, AKT1, and EZH2 overcomes resistance to BRAF and eIF4F inhibitors in BRAFV600E-mutant melanoma cells. The findings provide mechanistic insight into the interplay of translational, epigenetic, and survival pathways, supporting rational design of combinatorial therapies for resistant melanoma.

• SVA 3A/2B Proteins Counter Host DDX23 via Caspase-Dependent

  2026-05-02

  This study delineates the molecular interplay between Senecavirus A (SVA) and the host restriction factor DDX23, revealing distinct apoptotic pathways utilized by viral proteins 3A and 2B to undermine host defense. The work identifies key amino acids mediating these effects and offers mechanistic insights relevant for antiviral research and therapeutic targeting.

• Doxorubicin Hydrochloride in Cancer and Cardiotoxicity Model

  2026-05-02

  Harness Doxorubicin hydrochloride for precision cancer chemotherapy research and next-generation cardiotoxicity modeling. This article guides you through modern experimental workflows, advanced troubleshooting, and leverages new mechanistic insights—such as the ATF4/H2S antioxidation axis—to elevate your assay design and translational impact.

• Ethanol Disrupts Hippocampal Neurogenesis via mTOR-EZH2 Modu

  2026-05-01

  This study demonstrates that adolescent ethanol exposure impairs neural stem cell activation and dendritic spine remodeling in the adult mouse hippocampus through the mTOR-EZH2 pathway. The findings offer mechanistic insights into how binge drinking in adolescence leads to lasting deficits in neurogenesis, with partial reversibility through exercise or mTOR pathway inhibition.

• TaqI Restriction Endonuclease: Fast, Reliable DNA Digestion

  2026-04-30

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid, PCR, or genomic DNA, streamlining workflows that demand quick, reliable DNA digestion. Best suited for molecular biology research, this enzyme is not intended for diagnostic or clinical use. Its integrated tracer dyes and engineered efficiency address common bottlenecks in cloning and DNA manipulation protocols.

• Artemisitene Induces Calcium-Dependent Ferroptosis in CRC vi

  2026-04-30

  This study reveals that artemisitene triggers ferroptosis in colorectal cancer by disrupting the LSH–EWSR1 interaction, leading to calcium overload and lipid peroxidation. The findings identify a novel calcium-driven regulatory pathway for ferroptosis, providing a mechanistic foundation for new therapeutic approaches in CRC.

422 records 17/29 page Previous Next First page 上5页 1617181920 下5页 Last page